Fulgent Genetics Basic EPS 2015-2025 | FLGT
Fulgent Genetics basic eps from 2015 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Fulgent Genetics Annual Basic EPS | |
|---|---|
| 2024 | $-1.41 |
| 2023 | $-5.63 |
| 2022 | $4.76 |
| 2021 | $17.25 |
| 2020 | $9.44 |
| 2019 | $-0.02 |
| 2018 | $-0.31 |
| 2017 | $-0.14 |
| 2016 | $-1.00 |
| 2015 | $-0.61 |
| 2014 | $0.00 |
| Fulgent Genetics Quarterly Basic EPS | |
|---|---|
| 2025-03-31 | $-0.37 |
| 2024-12-31 | $-0.19 |
| 2024-09-30 | $-0.48 |
| 2024-06-30 | $-0.29 |
| 2024-03-31 | $-0.45 |
| 2023-12-31 | $-4.29 |
| 2023-09-30 | $-0.44 |
| 2023-06-30 | $-0.38 |
| 2023-03-31 | $-0.52 |
| 2022-12-31 | $-0.77 |
| 2022-09-30 | $0.06 |
| 2022-06-30 | $0.38 |
| 2022-03-31 | $5.09 |
| 2021-12-31 | $3.42 |
| 2021-09-30 | $4.13 |
| 2021-06-30 | $2.74 |
| 2021-03-31 | $6.96 |
| 2020-12-31 | $7.27 |
| 2020-09-30 | $2.11 |
| 2020-06-30 | $0.15 |
| 2020-03-31 | $-0.09 |
| 2019-12-31 | $-0.02 |
| 2019-09-30 | $0.08 |
| 2019-06-30 | $0.02 |
| 2019-03-31 | $-0.10 |
| 2018-12-31 | $-0.11 |
| 2018-09-30 | $-0.03 |
| 2018-06-30 | $-0.06 |
| 2018-03-31 | $-0.11 |
| 2017-12-31 | $-0.09 |
| 2017-09-30 | $-0.06 |
| 2017-06-30 | $0.00 |
| 2017-03-31 | $0.01 |
| 2016-12-31 | $0.15 |
| 2016-09-30 | $-0.44 |
| 2016-06-30 | $-0.66 |
| 2016-03-31 | $-0.05 |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2014-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.541B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.130B | 58.69 |
| Doximity (DOCS) | United States | $11.290B | 52.27 |
| Hims & Hers Health (HIMS) | United States | $11.277B | 117.16 |
| Tempus AI (TEM) | United States | $10.557B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.350B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.741B | 58.45 |
| Hinge Health (HNGE) | United States | $3.664B | 0.00 |
| Privia Health (PRVA) | United States | $2.391B | 163.42 |
| Schrodinger (SDGR) | United States | $1.574B | 0.00 |
| Phreesia (PHR) | United States | $1.516B | 0.00 |
| Enovis (ENOV) | United States | $1.502B | 8.37 |
| Clover Health Investments (CLOV) | United States | $1.496B | 0.00 |
| 10x Genomics (TXG) | United States | $1.496B | 0.00 |
| Azenta (AZTA) | United States | $1.427B | 66.30 |
| Omnicell (OMCL) | United States | $1.259B | 22.22 |
| Evolent Health (EVH) | United States | $1.119B | 95.30 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.462B | 0.00 |
| Talkspace (TALK) | United States | $0.415B | 124.00 |
| TruBridge (TBRG) | United States | $0.336B | 746.33 |
| Outset Medical (OM) | United States | $0.309B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.280B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| CapsoVision (CV) | United States | $0.211B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.155B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.85 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |